Validation of a scoring system to predict non-sentinel lymph node metastasis in melanoma

Journal of Surgical Oncology

Volumn 101, Issue 3, 2010, Pages 191-194

  Cadili, Ali ^a   Mckinnon, Greg ^b   Wright, Frances ^c   Hanna, Wedad ^c   Macintosh, Ethel ^d   Abhari, Zahra ^e   Dabbs, Kelly ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d HEALTH SCIENCES CENTRE   (Canada)

^e UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Melanoma; Metastasis; Non sentinel lymph nodes

Indexed keywords

ADULT; ARTICLE; CANADA; CANCER SIZE; CONTROLLED STUDY; CORRELATIONAL STUDY; HEALTH CENTER; HOSPITAL; HUMAN; HUMAN TISSUE; INFORMATION PROCESSING; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MELANOMA; MULTIVARIATE ANALYSIS; POPULATION; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SENTINEL LYMPH NODE BIOPSY; THICKNESS; VALIDATION STUDY;

HUMANS; LYMPHATIC METASTASIS; MELANOMA; MIDDLE AGED; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 77249148939     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21465     Document Type: Article

References (21)

1. Morton DL, Wanek L, Nizze JA, et al.: Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes: Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann Surg 1991;214:491-499.
2. Balch CM, Soong SJ, Gershenwald JE, et al.: Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001;19:3622-3634.
3. Cascinelli N, Morabito A, Santinami M, et al.: Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomised trial. WHO Melanoma Programme. Lancet 1998;351:793-796.
4. Veronesi U, Adamus J, Bandiera DC, et al.: Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 1982;49:2420-2430.
5. Morton DL, Wen DR, Wong JH, et al.: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
6. Vuylsteke RJ, van Leeuwen PA, Statius Muller MG, et al.: Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: Long-term follow-up results. J Clin Oncol 2003;21:1057-1065.
7. National Comprehensive Cancer Network (NCCN) clinical practice guidelines in oncology: Melanoma 2009.
8. Morton DL, Thompson JF, Cochran AJ, et al.: Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006; 355:1307-1317.
9. Elias N, Tanabe KK, Sober AJ, et al.: Is completion lymphadenectomy after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? Arch Surg 2004;139:40.
10. Cochran AJ, Roberts A,Wen D-R, et al.: Optimized assessment of sentinel lymph nodes for metastatic melanoma: Implications for regional surgery and overall treatment planning. Ann Surg Oncol 2004;11:156S-161S.
11. Urist M, Maddox WA, Kennedy JE, et al.: Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients. Cancer 1983;51:2152-2156.
12. Cadili A, Smylie M, Danyluk J, et al.: Prediction of Nonsentinel Lymph Node Metastasis in Malignant Melanoma. J Surg Res 2009;154:324-329.
13. van Akkooi AC, Nowecki ZI, Voit C, et al.: Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: A multicenter study in 388 patients with positive sentinel nodes. Ann Surg 2008;248:949-955.
14. Roka F, Mastan P, Binder M, et al.: Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients. Eur J Surg Oncol 2008;34:82-88.
15. Scolyer RA, Li LX, McCarthy SW, et al.: Immunohistochemical stains fail to increase the detection rate of micrometastatic melanoma in completion regional lymph node dissection specimens. Melanoma Res 2004;14:263-268.
16. Lens MB, Dawes M, Newton-Bishop JA, et al.: Tumour thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsy. Br J Surg 2002;89:1223-1227.
17. McMasters KM, Wong SL, Edwards MJ, et al.: Frequency of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol 2002;9:137-141.
18. Wagner JD, Gordon MS, Chuang TY, et al.: Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma. Cancer 2000;89:453-462.
19. Sabel MS, Griffith K, Sondak VK, et al.: Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. J Am Coll Surg 2005;201:37-47.
20. Cochran AJ, Wen DR, Huang RR, et al.: Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod Pathol 2004;17: 747-755.
21. Salti GI, Das Gupta TK: Predicting residual lymph node basin disease in melanoma patients with sentinel lymph node metastases. Am J Surg 2003;186:98-101.